06:03 AM EDT, 10/07/2025 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said in a regulatory filing Monday that it has appointed Cortney Caudill chief operating officer.
Caudill most recently served at Aeglea Biotherapeutics as chief product officer before joining Halozyme in 2023, the company said.